Skip to main content
倍益康 logo

倍益康 — Investor Relations & Filings

Ticker · 920199 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 360 across all filing types
Latest filing 2024-05-08 Earnings Release
Country CN China
Listing Beijing Stock Exchange 920199

About 倍益康

https://www.qlbeoka.com/

Beiyikang focuses on the research, development, and manufacturing of rehabilitation and physical therapy equipment. The company integrates professional medical technology with consumer-oriented health solutions. Its product lineup features percussive massage devices, oxygen concentrators, blood pressure monitors, and specialized physical therapy instruments for pain relief and muscle recovery. By utilizing advanced manufacturing processes and technological innovation, Beiyikang delivers products for sports recovery, clinical rehabilitation, and personal health management. The company prioritizes the incorporation of smart technology into its hardware to improve therapeutic outcomes and user experience across its range of recovery and wellness devices.

Recent filings

Filing Released Lang Actions
投资者关系活动记录表
Earnings Release Classification · 95% confidence The document is titled as an "投资者关系活动记录表" which translates to "Investor Relations Activity Record". It details a performance explanation meeting held on May 8, 2024, discussing the company's 2023 annual report results, including financial performance, product strategy, market competition, cash flow, net profit, and R&D investment. The content is a Q&A format typical of an earnings or performance explanation session. The document length is about 5075 characters, which is sufficient to contain substantive financial discussion but it is not a full formal financial report like an Annual Report (10-K) or Interim Report (IR). It is not a transcript of a conference call but a record of an investor relations meeting focused on explaining annual results. This fits the definition of an Earnings Release (ER) or more precisely a performance explanation meeting related to annual results. Given the detailed discussion of 2023 annual results and the nature of the document as a performance explanation meeting, the best fit is Earnings Release (ER). FY 2023
2024-05-08 Chinese
北京大成（成都）律师事务所关于四川千里倍益康医疗科技股份有限公司2023年年度股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the 2023 Annual General Meeting (AGM) of Sichuan Qianli Beiyikang Medical Technology Co., Ltd. It details the legality of the AGM's convening, attendance, voting procedures, and results. The document includes specific voting results on various agenda items from the AGM. It is not the AGM presentation materials themselves, nor is it the actual annual report or financial statements. Instead, it is a legal opinion related to the AGM proceedings and voting outcomes. This type of document fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it officially reports the voting results and validates the AGM process.
2024-05-08 Chinese
2023年年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a 2023 Annual General Meeting (AGM) resolution announcement for Sichuan Qianli Beiyikang Medical Technology Co., Ltd. It details the meeting date, attendance, agenda items, and voting results on various company reports and proposals, including the 2023 annual report, financial statements, profit distribution, auditor appointment, and remuneration plans. The document is a formal announcement of the resolutions passed at the AGM rather than the full reports themselves. It includes voting results and procedural compliance statements, which are typical for AGM resolution announcements. The document length is 5658 characters, which is consistent with an announcement rather than a full report. Therefore, the document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2024-05-08 Chinese
2023年年度报告业绩说明会预告公告
AGM Information Classification · 95% confidence The document is a notice announcing a scheduled performance explanation meeting related to the company's 2023 Annual Report. It references the already published 2023 Annual Report (公告编号：2024-018) and provides details about the meeting time, location, participants, and how investors can join and ask questions. The document itself does not contain the full annual report or detailed financial data but serves as an announcement for an event discussing the annual report. The document length is short (942 characters), and it fits the pattern of a report publication announcement or meeting notice rather than the report itself. Therefore, it should be classified as AGM Information (AGM-R) because it is about the Annual Report performance explanation meeting, which is a type of AGM-related presentation material.
2024-04-28 Chinese
第三届董事会第十七次会议决议公告
Board/Management Information Classification · 95% confidence The document is a board meeting resolution announcement from Sichuan Qianli Beiyikang Medical Technology Co., Ltd. It details the convening and attendance of the board meeting, the approval of the company's 2024 first quarter report, and voting results. The document references the actual quarterly report being disclosed separately on the Beijing Stock Exchange information platform, indicating this document is not the report itself but a board resolution about it. The document length is short (938 characters) and it serves as an announcement of the board meeting decisions rather than containing substantive financial data or the report itself. Therefore, it fits best under Board/Management Information (MANG) as it announces board meeting resolutions and decisions.
2024-04-25 Chinese
2024年一季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "2024 年第一季度报告" which translates to "2024 First Quarter Report." It contains detailed financial statements including consolidated and parent company balance sheets, profit and loss statements, cash flow statements, and notes on financial data for the period January to March 2024. The document explicitly states it is a quarterly report and includes comprehensive financial data and analysis for the quarter. It is unaudited but contains substantive financial information for a period shorter than a full fiscal year. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). Q1 2024
2024-04-25 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.